4-(2-Chlorobenzyloxy)-3,5-dimethylphenylboronic acid

Product Information

Molecular Formula:
C15H16BClO3
Molecular Weight:
290.55
Description
4-(2-Chlorobenzyloxy)-3,5-dimethylphenylboronic acid is a versatile compound utilized in the biomedical industry. It exhibits promising potential in the development of drugs to treat various diseases. This product can be employed as a key intermediate in the synthesis of pharmaceutical agents targeting specific receptors or enzymes involved in the treatment of certain cancers, inflammatory disorders, or metabolic conditions.
Synonyms
(4-((2-Chlorobenzyl)oxy)-3,5-dimethylphenyl)boronic acid; [4-[(2-chlorophenyl)methoxy]-3,5-dimethylphenyl]boronic acid; 4-(2'-Chlorobenzyloxy)-3,5-dimethylphen&; {4-[(2-Chlorophenyl)methoxy]-3,5-dimethylphenyl}boronic acid; (4-((2-Chlorobenzyl)oxy)-3,5-dimethylphenyl)boronicacid; 4-(2(2)-Chlorobenzyloxy)-3,5-dimethylphenylboronic acid
IUPAC Name
[4-[(2-chlorophenyl)methoxy]-3,5-dimethylphenyl]boronic acid
Canonical SMILES
B(C1=CC(=C(C(=C1)C)OCC2=CC=CC=C2Cl)C)(O)O
InChI
InChI=1S/C15H16BClO3/c1-10-7-13(16(18)19)8-11(2)15(10)20-9-12-5-3-4-6-14(12)17/h3-8,18-19H,9H2,1-2H3
InChI Key
UDKYOMYSPIEDTK-UHFFFAOYSA-N
Melting Point
234-238 °C (lit.)

Safety Information

Hazards
H315-H319-H335-H413
Precautionary Statement
P261-P305 + P351 + P338

Computed Properties

Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
4
Exact Mass
290.0881022 g/mol
Monoisotopic Mass
290.0881022 g/mol
Topological Polar Surface Area
49.7Ų
Heavy Atom Count
20
Formal Charge
0
Complexity
291
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
AU-2018273599-A1 Polysubstituted pyrimidines inhibiting the formation of prostaglandin E2, a method of production thereof and use thereof 2017-05-24
CA-3058795-A1 Polysubstituted pyrimidines inhibiting the formation of prostaglandin e2, a method of production thereof and use thereof 2017-05-24
CZ-308052-B6 Polysubstituted pyrimidines 2017-05-24
EP-3630730-A1 Polysubstituted pyrimidines inhibiting the formation of prostaglandin e2, a method of production thereof and use thereof 2017-05-24
US-2020199080-A1 Polysubstituted pyrimidines inhibiting the formation of prostaglandin e2, a method of production thereof and use thereof 2017-05-24
WO-2018215003-A1 Polysubstituted pyrimidines inhibiting the formation of prostaglandin e2, a method of production thereof and use thereof 2017-05-24
AU-2018273599-B2 Polysubstituted pyrimidines inhibiting the formation of prostaglandin E2, a method of production thereof and use thereof 2017-05-24
EP-3630730-B1 Polysubstituted pyrimidines inhibiting the formation of prostaglandin e2, a method of production thereof and use thereof 2017-05-24
US-11111219-B2 Polysubstituted pyrimidines inhibiting the formation of prostaglandin E2, a method of production thereof and use thereof 2017-05-24
US-2012149693-A1 Therapeutic compounds 2009-05-05
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International: 1-631-504-6093
  • US & Canada (Toll free): 1-844-BOC(262)-0123
  • 45-16 Ramsey Road, Shirley, NY 11967, USA
  • Email: info@bocsci.com
  • Fax: 1-631-614-7828
UK
  • 44-20-3286-1088
  • 85 Great Portland Street, London, W1W 7LT
  • Email: info@bocsci.com
Copyright © 2025 BOC Sciences. All rights reserved.
Top
0
Inquiry Basket

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x